University at Buffalo researchers will test the effectiveness of using stem cells from donors to treat patients with heart failure.
The National Heart, Lung and Blood Institute has awarded $2 million for the four-year translational animal study.
The results could pave the way for a similar trial in humans and eventually help make stem cell therapy more widely available (…)
Of all the alcoholic liver disease patients thronging the out-patient departments of the Post Graduate Institute of Medical Education and Research (PGIMER), nearly 50% are from Punjab.
What draws them to this institute is the stem cell treatment offered to the severe alcoholic hepatitis that acts as a boon.
PGI is the only tertiary hospital in the region which caters to this end-stage liver disease from Punjab, Himachal, Haryana and Chandigarh.
The stem cell treatment reports 78% success in cases of severe alcoholic hepatitis. A report on the same had been published in the prestigious American journal of gastroenterology this month. Moreover,
After extensively using stem cell therapy for treatment of leukemia, doctors are now pushing for using it to help cure solid tumours.
Doctors from various countries have congregated in the city to deliberate on the efficacy of using stem cells to treat the side-effects of chemotherapy, which, if given in high dosage, kills healthy cells as well.
“In several patients we have observed that the white blood cell count plummets following chemotherapy. This brings down the person’s resistance to infections. By transplanting stem cells we could counter that,” said Dr Ranjan Kumar Mohapatra, oncologist at Global Cancer Institute which is organising
Researchers have developed a new line of genetically modified pigs that do not reject transplants, an advance that allows for future research on stem cell therapies.
One of the biggest challenges for medical researchers studying the effectiveness of stem cell therapies is that transplants or grafts of cells are often rejected by the hosts.
This rejection can render experiments useless, making research into potentially life-saving treatments a long and difficult process.
Now, researchers at the University of Missouri have shown that a new line of genetically modified pigs will host transplanted cells without the risk of rejection.
“The rejection of transplants and grafts
Multiple Sclerosis Patients Update: After Second Stem Cell Treatment
It has been about 3 months since I last updated you on Preston Walker and Richard Humphries, the two Multiple Sclerosis Stem Cell Research pioneers who received their own Adult Stem Cells to improve their MS.
Since then, both have returned to Costa Rica to receive a second […]